Soligenix Inc. (SNGX)

2.05
0.02 0.98
NASDAQ : Health Technology
Prev Close 2.03
Open 2.02
Day Low/High 2.02 / 2.10
52 Wk Low/High 1.74 / 5.08
Volume 13.87K
Avg Volume 65.50K
Exchange NASDAQ
Shares Outstanding 8.73M
Market Cap 17.20M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results

Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results

2017 Non-Dilutive Funding Exceeds $8M

Soligenix Receives Additional NIAID Funding To Advance Development Of Heat Stable Ricin Vaccine

Awarded $2M to Advance Preclinical Efficacy Studies

Soligenix Announces Publication Of Its Phase 2 Long-term Follow-up Results Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients

At 12 Months SGX942 Found to be Safe and Well Tolerated with Multiple Potential Ancillary Benefits

EMC Buys $6.4M More of VMware

EMC Corp buys another 90,000 shares.

CEO Sells $6.1M Worth of Liberty Media

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

TheStreet Quant Rating: D (Sell)